Image For Activity Cover
Practical Use of Medication Treatment for Judges: A Discussion
President Judge Michael Barrasse, Judge in the 45th Judicial District Court of Common Pleas of Lackawanna County in Scranton, Pennsylvania; Hon. Phyllis McMillen, Oakland County Circuit Court (State of Michigan 6th Circuit); and Hon. Mary Jane Knisely, District Court Judge, 13th Judicial District, Yellowstone County, Montana
Target Audience
This webcast was developed for judges—whether presiding over state, municipal, general jurisdiction, treatment/specialty courts and/or whether they are law trained or not.
Webinar Description
This webinar, through a panel discussion, features judges from around the country who will discuss their experience with medication treatment (MAT) for alcohol and opiate addicted defendants and participants. These national experts will focus on the legal, ethical, and practical issues surrounding the use of MAT. This webinar builds on the information from the June 9th Webinar with Dr. Joshua Lee, Medications for Alcohol and Drug Use Disorders 101: The Science of Medication Treatment, which while helpful, is not required to attend this webinar.
Educational Objectives

At the conclusion of this activity, learners should be able to:

  1. Summarize what is Medication Treatment (MAT)
  2. Describe why MAT is an effective tool for litigants/defendants suffering from alcohol and/or drug addiction
  3. Identify the legal, ethical, and practical issues or challenges of MAT and the justice system
Availability: On-Demand
Expires on 07/14/2023
Cost: FREE
Credit Offered:
1 Attendance Credit
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible (in part) by grant nos. 6H79TI081968 and 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For Buprenorphine Training Inquiries, email PCSS.


Powered By